Evolus Inc EOLS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/14/21 EDT
9.06UNCH (UNCH)
Volume
4,734
Close
9.06quote price arrow up+0.40 (+4.62%)
Volume
938,934
52 week range
2.85 - 17.38

...

Loading . . .
  • Open8.72
  • Day High9.22
  • Day Low8.66
  • Prev Close8.66
  • 52 Week High17.38
  • 52 Week High Date03/24/21
  • 52 Week Low2.85
  • 52 Week Low Date10/29/20

Key Stats

  • Market Cap396.56M
  • Shares Out43.77M
  • 10 Day Average Volume0.87M
  • Dividend-
  • Dividend Yield-
  • Beta2.01
  • YTD % Change169.64

KEY STATS

  • Open8.72
  • Day High9.22
  • Day Low8.66
  • Prev Close8.66
  • 52 Week High17.38
  • 52 Week High Date03/24/21
  • 52 Week Low2.85
  • 52 Week Low Date10/29/20
  • Market Cap396.56M
  • Shares Out43.77M
  • 10 Day Average Volume0.87M
  • Dividend-
  • Dividend Yield-
  • Beta2.01
  • YTD % Change169.64

RATIOS/PROFITABILITY

  • EPS (TTM)-4.09
  • P/E (TTM)-2.22
  • Fwd P/E (NTM)-10.13
  • EBITDA (MRQ)-50.326M
  • ROE (MRQ)-318.71%
  • Revenue (MRQ)58.29M
  • Gross Margin (MRQ)67.42%
  • Net Margin (MRQ)-234.84%
  • Debt To Equity (MRQ)83.10%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Evolus Inc

There is no recent news for this security.

Profile

MORE
Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address the needs of the large and growing facial aesthetics market. It offers physicians and patients a compelling value proposition with DWP-450....
Vikram Malik
Chairman
David Moatazedi
President
Lauren Silvernail
Chief Financial Officer
Jeff Plumer
General Counsel
Address
520 Newport Center Dr Ste 1200
Newport Beach, CA
92660-7022
United States

Top Peers

SYMBOLLASTCHG%CHG
JNCE
Jounce Therapeutics Inc
7.67+0.44+6.09%
FBIO
Fortress Biotech Inc
3.68+0.07+1.94%
GRTS
Gritstone bio Inc
8.64+0.49+6.01%
FREQ
Frequency Therapeutics Inc
8.66+0.61+7.58%
CTMX
CytomX Therapeutics Inc
8.16-0.07-0.85%